Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.

Dhodapkar, M V; Kelly, T; Theus, A; Athota, A B; Barlogie, B; Sanderson, R D

Dhodapkar, M V; Kelly, T; Theus, A; Athota, A B; Barlogie, B; Sanderson, R D.

Affiliation

Dhodapkar MV; Division of Hematology-Oncology, University of Arkansas for Medical Sciences and VA Medical Center, Little Rock, USA.

Br J Haematol ; 99(2): 368-71, 1997 Nov.

Article in En | MEDLINE | ID: mdl-9375756

Subject(s)

Membrane Glycoproteins/blood; Metalloendopeptidases/blood; Multiple Myeloma/blood; Proteoglycans/blood; Adult; Aged; Blotting, Western; Female; Humans; Immunoblotting; Male; Middle Aged; Multiple Myeloma/enzymology; Syndecan-1; Syndecans; beta 2-Microglobulin/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Proteoglycans / Membrane Glycoproteins / Metalloendopeptidases / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links